Internal Medicine NewsInsulin degludec decreases rate, severity of hypoglycemic episodesJuly 3, 2017Diabetes
Internal Medicine NewsRed flags for type 2 diabetes seen 25 years before diagnosisJuly 1, 2017Diabetes
Internal Medicine NewsLEADER post hoc analysis: Mechanism behind liraglutide’s cardioprotective effects unclearJuly 1, 2017DiabetesCardiology
Internal Medicine NewsNocturia and sleep apneaJune 28, 2017NephrologySleep MedicineDiabetesMen's Health
Internal Medicine NewsFDA advisory committee supports new CV liraglutide indicationJune 21, 2017Diabetes
Internal Medicine NewsSPRINT: Intensive BP control cut cardiovascular risk in patients with prediabetesJune 21, 2017DiabetesCardiologyPreventive Care
Internal Medicine NewsDURATION-8: Exenatide/dapagliflozin efficacy holds up at 1 yearJune 21, 2017Diabetes
Internal Medicine NewsODYSSEY: Alirocumab improves lipids but not glycemic targets in 2DMJune 20, 2017Diabetes
Internal Medicine NewsIDegLira equals basal-bolus insulin in HbA1c, lowers hypoglycemia riskJune 19, 2017Diabetes
Internal Medicine NewsCANVAS: Canagliflozin cuts cardiovascular events, doubles risk of amputationsJune 14, 2017DiabetesPreventive Care
Internal Medicine NewsDEVOTE: Degludec and glargine had similar risk with less severe hypoglycemiaJune 14, 2017Diabetes
